| [1] |
Kondo Y, Yokosawa M, Kaneko S, et al. Review: transcriptional regulation of CD4+ T cell differentiation in experimentally induced arthritis and rheumatoid arthritis[J]. Arthritis Rheumatol, 2018, 70(5): 653-61. doi:10.1002/art.40398
|
| [2] |
Anandan M, Narayanan J. Role of T cells and cytokines in the pathogenesis of rheumatoid arthritis[J]. Biochem Biophys Rep, 2025, 44: 102278. doi:10.1016/j.bbrep.2025.102278
|
| [3] |
Schwarz T, Almanzar G, Wulfheide M, et al. Influence of a Th17-inducing cytokine milieu on phenotypical and functional properties of regulatory T cells in chronic inflammatory arthritis[J]. Int J Mol Sci, 2025, 26(15): 7339. doi:10.3390/ijms26157339
|
| [4] |
Jin XR, Bai YJ, Xu XH, et al. USP18-mediated protein stabilization of NOTCH1 is associated with altered Th17/Treg cell ratios and B cell-mediated autoantibody secretion in Sjögren syndrome[J]. Immunol Res, 2024, 73(1): 10. doi:10.1007/s12026-024-09566-6
|
| [5] |
Noack M, Miossec P. Th17 and regulatory T cell balance in autoimmune and inflammatory diseases[J]. Autoimmun Rev, 2014, 13(6): 668-77. doi:10.1016/j.autrev.2013.12.004
|
| [6] |
Xie XR, Liu Y, Li HJ. The Th17/Treg axis: a key to understanding and treating autoimmune disorders[J]. Open Life Sci, 2026, 21: 20251285. doi:10.1515/biol-2025-1285
|
| [7] |
Li GL, Xiong Y, Li ZM, et al. Gut microbiota-derived metabolites modulate Treg/Th17 balance: novel therapeutic targets in autoimmune diseases[J]. Front Immunol, 2025, 16: 1710733. doi:10.3389/fimmu.2025.1710733
|
| [8] |
Xu FT, Ling Y, Wei HX, et al. BMSC exosomes deliver JKAP to restore Th17/Treg balance via AKT/ERK, alleviating rheumatoid arthritis[J]. iScience, 2025, 28(7): 112832. doi:10.1016/j.isci.2025.112832
|
| [9] |
Mo ZC, Li HH, Huang WT, et al. Effects of ethanol extract of Songjie Fang on expression of tyrosine kinase and phosphatase-related molecules in TCR signaling pathway in rats with rheumatoid arthritis[J]. Chin Tradit Herb Drugs, 2020,51(2):406-11.
|
| [10] |
Mo ZC, Mei XL, Huang WT, et al. Anti-inflammatory Effect and Mechanism of Song Jie Fang Extract in Animal Inflammation Models[J]. Nat Prod Res Dev, 2018,30(2):304-9.
|
| [11] |
Zhang TQ, Xuan LL, Jiang RT, et al. Inhibition of component TZT-5 from leaves of Tripterygium wilfordii on rheumatoid arthritis in rats[J]. Chin Tradit Herb Drugs, 2013,44(12):1628-31. doi:10.7501/j.issn.0253-2670.2013.12.020
|
| [12] |
Shen X, Xue Y, Chen Y, et al. Establishment and Evaluation of Osteoarthritis Model in Vivo and in Vitro Under the Guidance of The Theory of"Wind-Cold-Dampness Causing Arthralgia"[J]. J Basic Chin Med, 2021,27(11):1721-4.
|
| [13] |
Wang C, Wang T, Yang WB, et al. Analysis of Modeling Methods for Bi Syndrome in Traditional Chinese Medicine[J]. J Basic Chin Med, 2009,15(12):907-8.
|
| [14] |
Yue J, Zhang YN, Ji XM, et al. Research Progress of Animal Model Combining Disease and Syndrome of Rheumatoid Arthritis[J]. Liaoning J Tradit Chin Med, 2016,43(5):1095-7.
|
| [15] |
Jiang H, Liu J, Gao JR, et al. Therapeutic Effect of Wuwei Wentong Chubi capsule on Rats with Stagnation of Wind, Cold and Damp Syndrome in Rheumatoid Arthritis[J]. Rheumatism Arthritis, 2012,1(6):23-7.
|
| [16] |
Alivernini S, Firestein GS, McInnes IB. The pathogenesis of rheumatoid arthritis[J]. Immunity, 2022, 55(12): 2255-70. doi:10.1016/j.immuni.2022.11.009
|
| [17] |
Ziyadullaev SK, Khudaiberdiev SS, Aripova TU, et al. Synovial fluid as a crucial component of the joint microenvironment in rheumatoid arthritis[J]. Immune Netw, 2025, 25(2): e2. doi:10.4110/in.2025.25.e2
|
| [18] |
Yue SR, Fan JY, Xie DL, et al. Unveiling the therapeutic potential: targeting fibroblast-like synoviocytes in rheumatoid arthritis[J]. Expert Rev Mol Med, 2025, 27: e18. doi:10.1017/erm.2025.11
|
| [19] |
Liu YX, Zhu YF, Liu Y, et al. Quantity of Th17 and Treg cells in the peripheral blood from patients with rheumatoid arthritis: a meta analysis[J]. J Zhengzhou Univ (Med Sci), 2015,50(5):606-10.
|
| [20] |
Taha HA, Hozayen WG, Okasha AM, et al. Investigating the balance between Th17/treg cells in rheumatoid arthritis and its association with disease activity[J]. J Child Sci, 2019, 9(1): e75-83.
|
| [21] |
Najm A, Ferguson LD, McInnes IB. Cytokine pathways driving diverse tissue pathologies in rheumatoid arthritis[J]. Arthritis Rheumatol, 2025 sep 9. doi:10.1002/art.43376 .
|
| [22] |
Raterman HG, Adami G, Clark P, et al. Osteoimmunology: can we prevent bone loss in rheumatoid arthritis with modern antirheumatic drugs[J]? Calcif Tissue Int, 2026, 117(1): 55. doi:10.1007/s00223-026-01504-y
|
| [23] |
Henningsson L, Eneljung T, Jirholt P, et al. Disease-dependent local IL-10 production ameliorates collagen induced arthritis in mice[J]. PLoS One, 2012, 7(11): e49731. doi:10.1371/journal.pone.0049731
|
| [24] |
Charbonnier LM, Han WGH, Quentin J, et al. Adoptive transfer of IL-10-secreting CD4+CD49b+ regulatory T cells suppresses ongoing arthritis[J]. J Autoimmun, 2010, 34(4): 390-9. doi:10.1016/j.jaut.2009.10.003
|
| [25] |
Hu YH, Zhao QH, Dai HR, et al. Metabolic reprogramming as a therapeutic target for modulating the Th17/Treg balance in autoimmune diseases: a comprehensive review[J]. Front Immunol, 2025, 16: 1687755. doi:10.3389/fimmu.2025.1687755
|
| [26] |
Kuai JJ, Chen Z, He J, et al. Promising TNF-α inhibitors: Targeting pathogenic TNF-α/TNFR signaling to restore Th17/Treg balance in rheumatoid arthritis[J]. J Pharm Anal, 2026, 16(3): 101382. doi:10.1016/j.jpha.2025.101382
|
| [27] |
Zhang X, Zhang XL, Zhuang LL, et al. Decreased regulatory T-cell frequency and interleukin-35 levels in patients with rheumatoid arthritis[J]. Exp Ther Med, 2018,16(6):5366-72.
|
| [28] |
Miller S, Eizenberg-Magar I, Reich-Zeliger S, et al. Independent and temporally separated dynamics for RORγt and Foxp3 during Th17 differentiation[J]. Front Immunol, 2025, 16: 1462045. doi:10.3389/fimmu.2025.1462045
|
| [29] |
Robert M, Miossec P. IL-17 in rheumatoid arthritis and precision medicine: from synovitis expression to circulating bioactive levels[J]. Front Med, 2019, 5: 364. doi:10.3389/fmed.2018.00364
|
| [30] |
Shen M. Detection and clinical significance of peripheral blood Th17 cells, regulatory T cells, and related cytokine levels in patients with rheumatoid arthritis[J]. Chin Remedies Clin, 2020,20(3):393-5.
|
| [31] |
Li Y, Qi WF, Shi YQ, et al. Clinical effect of TNF-α antagonist on treatment of patients with rheumatoid arthritis[J]. Chin J Nosocomiol, 2021, 31(1): 73-7.
|
| [32] |
Zhang F, Dai ZS, Lin Y, et al. Mechanistic Studies of Th17/Treg Imbalance Influenced by Exogenous Wind-cold-damp Pathogens on the Development of Rheumatoid Arthritis[J]. J Hunan Univ Chin Med, 2021, 41(11): 1657-62.
|